ImportRefusal LogoImportRefusal

Glaxo Smithkline

⚠️ Moderate Risk

FEI: 3009135020 • Solan • INDIA

FEI

FEI Number

3009135020

📍

Location

Solan

🇮🇳

Country

INDIA
🏢

Address

Badi, , Solan, , India

Moderate Risk

FDA Import Risk Assessment

36.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
1
Unique Violations
1/5/2021
Latest Refusal
1/5/2021
Earliest Refusal

Score Breakdown

Violation Severity
80.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

721×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

Refusal History

DateProductViolationsDivision
1/5/2021
60ZCA99ANTIPARASITIC, N.E.C.
72NEW VET DR
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Glaxo Smithkline's FDA import refusal history?

Glaxo Smithkline (FEI: 3009135020) has 1 FDA import refusal record(s) in our database, spanning from 1/5/2021 to 1/5/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxo Smithkline's FEI number is 3009135020.

What types of violations has Glaxo Smithkline received?

Glaxo Smithkline has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Glaxo Smithkline come from?

All FDA import refusal data for Glaxo Smithkline is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.